Qritive receives Class C IVD certification from the Health Sciences Authority (HSA) Singapore for its QAi Prostate Dx module.

We are proud to announce that Qritive has achieved Class C IVD certification from the Health Sciences Authority (HSA) Singapore for our QAi Prostate Dx module.

This certification marks a significant milestone in our commitment to delivering cutting-edge solutions in the field of digital pathology. Our QAi Prostate Dx module utilizes deep learning to provide accurate and reliable assessments, empowering pathologists with invaluable insights for enhanced patient care. More information about the product can be found here – https://qritive.com/product-qai-prostate/

At Qritive, we strive for excellence in everything we do, and this certification is a testament to the dedication and hard work of our team. We are grateful for the trust and support of our partners and clients who have been instrumental in this achievement. About Qritive

Qritive, headquartered in Singapore with operations in the US and India, is transforming digital pathology through advanced AI-powered solutions that support cancer diagnosis and improve health outcomes.

By leveraging cutting-edge deep learning technology, Qritive supports pathologists in the interpretation of pathology assessments and enhances pathology workflows—enabling faster, more accurate diagnoses and reducing time to treatment.

Qritive is committed to empowering healthcare professionals around the world with tools that promote collaboration and high performance, regardless of complexity or distance.

Get in Touch

Want to learn more about our solutions or explore potential collaborations?

Visit www.qritive.com or contact us at info@qritive.com